Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.
about
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaGPC-3 in hepatocellular carcinoma: current perspectivesGlypican-3 Targeting Immunotoxins for the Treatment of Liver CancerConstruction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapyHuman Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.New Life for Immunotoxin Cancer Therapy.Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinomaClinical implications of basic research in hepatocellular carcinoma.Tumour-associated antigens and their anti-cancer applications.Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Selective cytotoxicity of a novel immunotoxin based on pulchellin A chain for cells expressing HIV envelope.Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.Frontiers and Opportunities: Highlights of the 2 Annual Conference of the Chinese Antibody SocietyHeparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and ProgressionApatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
P2860
Q26772321-D1290045-9FEB-4FB7-8639-863EA5EAB906Q28066774-5DA76B5C-B25F-47A3-A400-E9F44E53E387Q28077270-19F065EB-D4E9-4C50-A731-0D1B82F3F22AQ33779122-FDF1CFE9-8F34-4A04-B644-B2FDDB70D015Q35762228-F239957B-CAAF-4723-BADB-E318160B5519Q36642838-4826FE5B-4BC7-498D-A235-7133C2624B49Q36906823-D66E2800-158E-442B-B42C-5504D4E446D0Q37282388-17B9C1C3-20FB-455F-A477-7F349199F8F1Q37289933-1FA857F6-20BE-4257-AB28-0C7E50A6485DQ38725552-9704D296-2384-4457-8441-B583191673D2Q39016197-0712486B-F6C6-47D0-B742-84692C62D47BQ39378285-74D93E26-C689-47DD-AFF4-9C3875F93113Q40101404-49FE6244-6BEB-4A54-89D3-2389CAE001BFQ47119441-28FEBD77-9EEF-48A3-BF2E-AFC8CD478510Q47816782-93B2AC50-758E-4782-8DB3-9E67863F2040Q48355318-8ED5EB5F-EEA2-47AB-9AD4-DB573C3ED168Q55180894-741CCF1A-7783-43A5-8010-41337BB07E36Q58556647-77DE9A2C-0CBC-4EE0-9875-3D052E314367Q58705289-5E81D85B-C245-4348-BC55-76F733D7B2DEQ58790284-36B2FEBE-AE9E-4F04-AF1A-001B98F72ED8
P2860
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@ast
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@en
type
label
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@ast
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@en
prefLabel
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@ast
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@en
P2093
P2860
P356
P1476
Immunotoxin targeting glypican ...... nalling and protein synthesis.
@en
P2093
Dimiter S Dimitrov
Mingqian Feng
Mitchell Ho
Zhewei Tang
P2860
P2888
P356
10.1038/NCOMMS7536
P407
P50
P577
2015-03-11T00:00:00Z
P5875
P6179
1036373338